Based on the information available, there is an exception to the Vascepa (icosapent ethyl) deductible requirement for patients with specific health insurance plans. According to the Vascepa Copay Savings Program, "If you have a high deductible health plan, you may be eligible to pay as little as $0 for your Vascepa prescription" [1]. However, it is important to note that this program is subject to terms and conditions, and eligibility is determined by the program administrator.

Additionally, it is worth mentioning that according to DrugPatentWatch.com, Vascepa's patent expired in January 2020 [2]. This means that generic versions of the drug may become available, which could potentially lower the cost for patients and reduce or eliminate the need for a deductible. However, it is important to consult with a healthcare provider and insurance company to understand the specific coverage and cost for Vascepa or its generic equivalents.

In summary, there is an exception to the Vascepa deductible requirement for patients with high deductible health plans through the Vascepa Copay Savings Program. Furthermore, the patent for Vascepa has expired, which may lead to the availability of generic versions and a potential reduction in cost.

Sources:
[1] Vascepa Copay Savings Program. (n.d.). Retrieved from <https://www.vascepa.com/savings-support>
[2] DrugPatentWatch.com. (2021). Vascepa (icosapent ethyl). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa>